Structure-based drug design for G protein-coupled receptors

Area of Science:

• Structural biology
• Medicinal chemistry
• Pharmacology

Background:

• G protein-coupled receptors (GPCRs) are critical drug targets.
• Understanding GPCR structural biology has rapidly advanced in recent years.
• New protein-ligand complex structures are frequently published.

Purpose of the Study:

• To outline key topics in GPCR structural biology.
• To present recent examples of structure- and fragment-based drug design.
• To discuss the implications of new structural data for drug discovery.

Main Methods:

• Review of recent scientific literature on GPCR structural biology.
• Analysis of published X-ray structures of GPCRs.
• Examination of ligand interactions (antagonists, agonists) with GPCRs.

Main Results:

• A transformation in GPCR structural biology understanding over the past five years.
• Numerous new GPCR-ligand complex structures have been elucidated.
• A table detailing GPCR X-ray structures and their ligand interactions is provided.

Conclusions:

• New structural insights into GPCRs offer significant potential for medicinal chemists.
• Structure- and fragment-based drug design approaches are advancing for GPCR targets.
• The discussed data implications can profoundly influence future drug design strategies.